Development of a marburgvirus subunit vaccineadjuvanted with a novel TLR7/TLR8 agonist
Active Project Grant Awarded Last action
- Award ID
- R43AI181292
- Recipient
-
Abvacc, Inc. UEI K5MSGRFGVVZ9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,492,782
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 91% complete
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $297,099 | |
| Amendment | $297,099 | |
| Amendment | $299,528 | |
| Amendment | $299,528 | |
| Original award | $299,528 |
Quick answers
Who received award R43AI181292?
R43AI181292 was awarded to Abvacc, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 26, 2024.
How much is award R43AI181292 worth?
$1,492,782 has been obligated on R43AI181292.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award